Skip to main content
. 2016 Oct;109:366–375. doi: 10.1016/j.neuropharm.2016.07.004

Table 2.

Pharmacokinetics of NDMC in mice after p.o. administration.

Dose (mg/kg) Half-life (h) Cmax (μg/ml) AUC (h*μg/ml) Tmax (h)
3 5.6 ± 0.6 1.19 ± 2.53 11.15 ± 1.66 2.0 ± 0.9
10 4.6 ± 1.6 1.91 ± 1.34 14.72 ± 4.38 3.0 ± 0.0
30 4.7 ± 0.3 3.31 ± 1.01 32.28 ± 5.09 2.7 ± 0.6

Data are means ± SD, n = 3 per group.